Clinical Trial: Evaluation of a Nigella Sativa Extract (10% Thymoquinone, Nisatol®) in Perimenopausal Women With Metabolic Syndrome
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Metabolic Syndrome
Study Type: INTERVENTIONAL
Official Title: Evaluation of the Efficacy of a Nigella Sativa Extract Standardized to 10% Thymoquinone (Nisatol®) in Improving Metabolic and Blood Pressure Parameters and Quality of Life in Perimenopausal Women With
Brief Summary:
A prospective, multicenter, randomized controlled study evaluating the efficacy and safety of a Nigella sativa extract standardized to 10% thymoquinone (Nisatol®) in perimenopausal women with metabolic syndrome.The study will assess changes in metabolic and blood pressure parameters, as well as improvements in menopausal symptoms and quality of life.
Read more